Topic: United States
(Reuters) - Biogen Idec Inc's multiple sclerosis drug met the main goal of a closely watched clinical study, the biotechnology company said on Wednesday.Biogen said the results of the Confirm Phase III study showed that BG-12, administered either twice a day or ...
(Reuters) - Novartis's recently acquired eyecare business Alcon is facing a U.S. government investigation into alleged healthcare fraud, the Swiss drugmaker said on Tuesday.Alcon received a subpoena from the U.S. Department of Health and Human Services on September 23 requesting the production ...
Swiss pharmaceutical giant Novartis said on Tuesday it would slash 2,000 jobs, mostly in Switzerland and the United States, despite reporting third quarter net profits of $3.53 billion (2.5 billion euros).The firm said in a statement that profits for the quarter were ...
ZURICH (Reuters) - Novartis AG is slashing 2,000 jobs in Switzerland and the United States to keep costs under control in the face of growing price pressures and the strong Swiss franc, the Swiss drugmaker said on Tuesday.The Basel-based group has already ...
LONDON (Reuters) - Europe will strictly limit the amount of information that drugmakers can supply to the public on prescription-only medicines and retain a ban on advertising under proposed rules set out on Tuesday.The latest proposals from the European Commission amend those ...
(Reuters) - AstraZeneca Plc said on Thursday it will cut about 400 jobs from its U.S. commercial business as Britain's second-largest drugmaker seeks to reduce costs.The cuts will hit the company's U.S. headquarters in Wilmington, Delaware, as well as some field-based, non-sales ...
(Reuters) - AstraZeneca went back to court on Wednesday to defend the U.S. patent on its multibillion-dollar cholesterol fighter Crestor in the face of an appeal by generic drugmakers.Industry analysts believe the British company is likely to win the case, protecting exclusivity ...
NEW YORK (Reuters) - The U.S. Food and Drug Administration appears to be on the verge of issuing long-awaiting guidelines for the development of generic versions of complex biotechnology medicines.The FDA still plans to release the guidance by the end of the ...
(Reuters) - Patients with the most serious form of childhood arthritis can get substantial symptom relief from a Novartis drug, researchers said on Friday, raising hopes for a product that had a recent setback in its application to treat gout.Ilaris, or ACZ885, ...
NEW YORK (Reuters) - Pfizer Inc reached a settlement with Dr. Reddy's Laboratories , an Indian drugmaker that has been fighting in court to launch cheaper generic forms of Pfizer's blockbuster cholesterol fighter, the companies said on Wednesday .Dr. Reddy's in 2009 ...
Photo Gallery
-
South Korea Koreas Clash
South Korean Foreign Minister Kim Sung-hwan, right, shakes hands with U.S ...AP News - -
Hawks Kings Basketball
Sacramento Kings forward Carl Landry, center, goes to the basket against Atlanta ...AP News - -
Blue Jackets Coyotes Hockey
Columbus Blue Jackets' R.J. Umberger (18) scores a goal against Phoenix ...AP News -
